Fuller & Thaler Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-111
| Closed | -$3K | – | 547 |
|
|
2021
Q4 | $3K | Sell |
111
-182
| -62% | -$4.92K | ﹤0.01% | 531 |
|
|
2021
Q3 | $8K | Sell |
293
-521,967
| -100% | -$14.3M | ﹤0.01% | 501 |
|
|
2021
Q2 | $16.1M | Buy |
522,260
+203,554
| +64% | +$6.27M | 0.1% | 171 |
|
|
2021
Q1 | $8.34M | Sell |
318,706
-983,309
| -76% | -$25.7M | 0.06% | 226 |
|
|
2020
Q4 | $32.8M | Buy |
1,302,015
+318,620
| +32% | +$8.02M | 0.3% | 102 |
|
|
2020
Q3 | $20.5M | Buy |
983,395
+26,471
| +3% | +$552K | 0.26% | 110 |
|
|
2020
Q2 | $22.7M | Buy |
956,924
+455,532
| +91% | +$10.8M | 0.3% | 96 |
|
|
2020
Q1 | $9.02M | Sell |
501,392
-17,879
| -3% | -$322K | 0.15% | 139 |
|
|
2019
Q4 | $12.3M | Sell |
519,271
-312,976
| -38% | -$7.42M | 0.14% | 150 |
|
|
2019
Q3 | $22.9M | Buy |
832,247
+671,190
| +417% | +$18.4M | 0.27% | 112 |
|
|
2019
Q2 | $5.33M | Buy |
+161,057
| New | +$5.33M | 0.06% | 205 |
|
|
2015
Q3 | – | Sell |
-158
| Closed | -$3K | – | 752 |
|
|
2015
Q2 | $3K | Buy |
+158
| New | +$3K | ﹤0.01% | 625 |
|